Search research articles
Contact Us
Filters
Showing results (51-60 of 144) with videos related to
Page
of 15
Sort By:
Archives of Cardiovascular Diseases
|
December 5, 2017
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact
Christophe Bauters, Olivier Tricot, Gilles Lemesle, et al.
Presse Medicale (Paris, France : 1983)
|
September 2, 2019
[Myalgia and statins: Separating the true from the false]
Jacques Blacher, Eric Bruckert, Michel Farnier, et al.
Journal of Comparative Effectiveness Research
|
March 9, 2023
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
Jean Ferrières, Eric Bruckert, Michel Farnier, et al.
European Journal of Preventive Cardiology
|
May 18, 2023
Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey
Isabelle M Kouame, Michel Farnier, Frédéric Chague, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 6, 2021
PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction
Marianne Zeller, Gilles Lambert, Michel Farnier, et al.
Journal of Clinical Lipidology
|
July 12, 2017
Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years
Michel Farnier, Helen M Colhoun, William J Sasiela, et al.
Atherosclerosis
|
July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
Michel Farnier, John R Guyton, Erin Jensen, et al.
Frontiers in Cardiovascular Medicine
|
March 30, 2026
Lipid management in high cardiovascular risk patients in France: a comparison with rest of Europe patients from 1-year follow-up of SANTORINI
Jean Ferrières, Kausik K Ray, Alberico L Catapano, et al.
European Heart Journal
|
March 23, 2005
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia
Michel Farnier, Mason W Freeman, Geraldine Macdonell, et al.
Journal of Personalized Medicine
|
June 24, 2022
Retinal Microvascular Changes in Familial Hypercholesterolemia: Analysis with Swept-Source Optical Coherence Tomography Angiography
Pétra Eid, Louis Arnould, Pierre-Henry Gabrielle, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 144) with videos related to
Sort By:
Page
of 15
Archives of Cardiovascular Diseases
|
December 5, 2017
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact
Christophe Bauters, Olivier Tricot, Gilles Lemesle, et al.
Presse Medicale (Paris, France : 1983)
|
September 2, 2019
[Myalgia and statins: Separating the true from the false]
Jacques Blacher, Eric Bruckert, Michel Farnier, et al.
Journal of Comparative Effectiveness Research
|
March 9, 2023
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
Jean Ferrières, Eric Bruckert, Michel Farnier, et al.
European Journal of Preventive Cardiology
|
May 18, 2023
Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey
Isabelle M Kouame, Michel Farnier, Frédéric Chague, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 6, 2021
PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction
Marianne Zeller, Gilles Lambert, Michel Farnier, et al.
Journal of Clinical Lipidology
|
July 12, 2017
Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years
Michel Farnier, Helen M Colhoun, William J Sasiela, et al.
Atherosclerosis
|
July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
Michel Farnier, John R Guyton, Erin Jensen, et al.
Frontiers in Cardiovascular Medicine
|
March 30, 2026
Lipid management in high cardiovascular risk patients in France: a comparison with rest of Europe patients from 1-year follow-up of SANTORINI
Jean Ferrières, Kausik K Ray, Alberico L Catapano, et al.
European Heart Journal
|
March 23, 2005
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia
Michel Farnier, Mason W Freeman, Geraldine Macdonell, et al.
Journal of Personalized Medicine
|
June 24, 2022
Retinal Microvascular Changes in Familial Hypercholesterolemia: Analysis with Swept-Source Optical Coherence Tomography Angiography
Pétra Eid, Louis Arnould, Pierre-Henry Gabrielle, et al.
Page
of 15